Article Details

Emerging Seattle-Based Sana Biotechnology Seeks to Raise $150 Million IPO

Retrieved on: 2021-01-13 18:33:45

Tags for this article:

Click the tags to see associated articles and topics

Emerging Seattle-Based Sana Biotechnology Seeks to Raise $150 Million IPO. View article details on hiswai:

Excerpt

Ultimately, this technology may help researchers produce hypoimmunogenic stem cells that are capable of differentiation into any cell type. In turn, these ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo